ACS Chemical Neuroscience

ACS Chemical Neuroscience
Title	ACS Chemical Neuroscience
Discipline	Chemistry; Neuroscience
Abbreviation	ACS Chem. Neurosci.
Publisher	American Chemical Society
Country	United States
History	2010–present
Frequency	Monthly
Impact factor	6.7 (example)

ACS Chemical Neuroscience

ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society focusing on the interface of chemistry and neuroscience. The journal covers research that connects molecular design, chemical tools, and biological mechanisms relevant to neurology, psychiatry, and neurodegeneration across model organisms such as Caenorhabditis elegans, Drosophila melanogaster, Mus musculus, and Homo sapiens. It attracts submissions from investigators affiliated with institutions like Harvard University, Massachusetts Institute of Technology, Stanford University, and University of Oxford.

History

The journal was launched by the American Chemical Society in 2010 amid growing cross-disciplinary interest exemplified by programs at the National Institutes of Health, European Research Council, and centers such as the Salk Institute and Max Planck Society. Early editorial leadership included scientists with appointments at Columbia University, Yale University, Johns Hopkins University, and University of California, San Francisco, reflecting collaborations with laboratories of investigators like those at Cold Spring Harbor Laboratory and Karolinska Institutet. The title expanded its scope during the 2010s alongside initiatives sponsored by organizations such as the Wellcome Trust and consortium efforts like the BRAIN Initiative.

Scope and Content

The journal publishes original research articles, reviews, perspectives, and methods that intersect with topics addressed at venues such as the Society for Neuroscience annual meeting, the Gordon Research Conferences, and symposia at the American Association for the Advancement of Science. Article topics often reference molecular targets implicated in Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, and techniques relevant to laboratories at National Institute of Mental Health, Laboratory of Molecular Biology, and regional hubs like Riken. Contributions commonly involve chemical probes, imaging agents, optogenetic tools developed in groups at University of California, Berkeley, protein aggregation studies linked to work at Rockefeller University, and neurotransmitter chemistry paralleling research at University College London.

Publication Details

Published monthly, the journal follows production standards common to publishers including Nature Publishing Group, Elsevier, and Springer Nature. Manuscripts undergo formatting consistent with style guides used by Journal of the American Chemical Society and related ACS titles. Article types include full papers, communications, minireviews, and topical collections often organized around conferences such as Keystone Symposia and workshops hosted by institutions like the Scripps Research Institute. The journal employs digital object identifiers similar to systems used by CrossRef and archiving practices coordinated with repositories like PubMed Central where permitted.

Abstracting and Indexing

ACS Chemical Neuroscience is indexed in major databases that also list journals from Clarivate Analytics, Scopus, and PubMed. It appears in citation indexes alongside titles from Proceedings of the National Academy of Sciences, Neuron, and Journal of Neuroscience. Metrics reported by services such as Journal Citation Reports and aggregation platforms like Google Scholar influence visibility among researchers at Imperial College London, University of Toronto, and research hospitals including Mayo Clinic and Cleveland Clinic.

Reception and Impact

The journal has been cited in literature involving collaborative projects funded by agencies such as the National Science Foundation, National Institute on Drug Abuse, and philanthropic organizations like the Alzheimer's Association. Its articles are read by chemists and neuroscientists from centers including Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center and have informed translational initiatives at biotechnology firms and startups emerging from incubators such as Cambridge Innovation Center and Plug and Play Tech Center. Coverage of high-profile studies has appeared in science sections of outlets like The New York Times, The Guardian, and reports around meetings at Cold Spring Harbor Laboratory.

Notable Articles and Special Issues

Notable contributions included studies on small-molecule modulators of synaptic proteins linked to work at Scripps Research, imaging agents for amyloid reviewed in symposia at Karolinska Institutet, and chemical tools enabling optogenetic applications developed in collaborations involving MIT and Stanford University. Special issues have been organized around themes aligned with programs sponsored by Howard Hughes Medical Institute, workshops at Wellcome Trust Centre for Neuroimaging, and anniversaries coinciding with meetings of the Society for Neuroscience and American Chemical Society national meetings.

Editorial Board and Peer Review Process

The editorial board comprises academics and industry scientists affiliated with institutions such as University of California, San Diego, University of Pennsylvania, Princeton University, ETH Zurich, University of Cambridge, and pharmaceutical companies collaborating with consortia like the Structural Genomics Consortium. Peer review is single- or double-blind depending on editorial policy, drawing reviewers from networks that include investigators at Brown University, Duke University, University of Michigan, Peking University, and Tsinghua University. The journal adheres to ethical standards promoted by organizations such as the Committee on Publication Ethics and indexing services managed by Clarivate Analytics.

Category:Academic journals